Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: A flow cytometric method for ligand-receptor interaction

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 2, 2008, Pages 210-219

  Tetik, Sermin ^a   Uras, Fikriye ^a   Ekşioǧlu Demiralp, Emel ^a   Turay Yardimci, K ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Flow cytometry; Glycoprotein IIb; IIIa; Low density lipoprotein; Microbeads; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; LOW DENSITY LIPOPROTEIN; POLYSTYRENE;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; LIGAND BINDING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; THROMBOCYTE;

BINDING SITES; BLOOD PLATELETS; FLOW CYTOMETRY; HUMANS; LIGANDS; LIPOPROTEINS, LDL; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 40549135625     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607303781     Document Type: Article

References (53)

1. Eksioglu-Demiralp E., Kitada S., Carson D. A method for functional evaluation of caspase activation pathways in intact lymphoid cells using electroporation-mediated protein delivery and flow cytometric analysis. J Immunol Methods. 2003 ; 275: 41-56.
2. Ulutin ON Atherosclerosis and Hemostasis. Semin Thromb Hemost. 1986 ; 12: 156-174.
3. Yardimci T., Yaman A., Ulutin ON Characterization of platelet gamma glutamyltransferase and its alteration in cases of atherosclerosis. Clin Appl Thromb Hemost. 1995 ; 1103-1113.
4. Plow EF, Byzova T. The biology of glycoprotein IIb/IIIa. Coron Artery Dis. 1999 ; 10: 547-551.
5. Huo Y., Ley KF Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med. 2004 ; 14: 18-22.
6. Plow EF, D'Souza SE, Ginsberg MH Ligand binding to GpIIb/IIIa: a status report. Semin Thromb Hemost 1992 ; 18: 324-338.
7. Sims PJ, Ginsberg MH, Plow EF, Shattil S. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb/IIIa complex. J Biol Chem. 1991 ; 226: 7345-7365.
8. Ozsavci D., Yardimci KT, Yanikkaya-Demirel G., Eksioglu-Demiralp E., Uras F., Önder E. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia. Platelets. 2002 ; 13: 223-229.
9. Rosenson RS, Lowe GDO. Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis. 1998 ; 140: 271-280.
10. Holvoet P., Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol. 1997 ; 8: 320-328.
11. Bruckdorfer KR Lipoprotein, platelet and coagulation. In: Betteridge DJ, Illingworth DR, Shepherd J, eds. Lipoproteins in Health and Diseases. London, United Kingdom: Oxford Univ Press ; 1999: 608-642.
12. Umemura K., Saniabadi AR Aggregation of human blood platelets by remnant-like lipoprotein particles. Nippon Yakurigaku Zasshi. 2000 ; 116: 269-274.
13. Aviram M. LDL-Platelet interaction under oxidative stress induces macrophage foam cell formation. Thromb Haemost. 1995 ; 74: 560-564.
14. Aviram M., Brook JG Platelet enhancement of macrophage cholesterol accumulation: a novel mechanism for atherogenesis. In: Halpem MJ, ed. Molecular Biology of Atherosclerosis. Proceeding of the 57th European Atherosclerosis. Society Meeting. London, United Kingdom: John Libbey and Co Ltd ; 1992 ; 14: 67-71.
15. Woods VL, Wolff LE, Keller DM Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem. 1986 ; 261: 15242-15247.
16. Nofer JR, Tepel M., Kehrel B., et al. Low density lipoproteins inhibited Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation. 1997 ; 95: 1370-1377.
17. Leake DS Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions ? Atherosclerosis. 1997 ; 129: 149-157.
18. Wang JS, Chow SE, Chen JK, Wong MK Effects of exercise training on oxidized LDL-mediated platelet function in rats. Thromb Haemost. 2000 ; 83: 503-508.
19. Ardlie NG Lipoproteins, platelet function and blood coagulation. In: Miller NE, Lewis B, eds. Lipoproteins, Atherosclerosis and Coronary Heart Disease. Amsterdam, the Netherlands: Elsevier/North Holland Biomedical Press ; 1994: 107-125.
20. Zieseniss S., Zahler S., Muller I., Hermetter A., Engelmann B. Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity. J Biol Chem. 2001 ; 276: 19828-19835.
21. Volf E., Koller E., Bielek E., Koller F. Colocalization of gold-labelled LDL and fibrinogen on platelets. Enhanced fibrinogen binding induced by LDL. Am J Physiol. 1997 ; 273: C118 - C129.
22. Zhao B., Dierichs R., Lio B., Berkes P. Gold-labelled low density lipoproteins bind to washed human platelets. Platelets. 1994 ; 5: 113-120.
23. Pedreno J., Fernandez R., Cullane C. Platelet integrin alpha IIb/beta3 (GpIIb/IIIa) is not implicated in the binding of LDL to intact resting platelets. Arterioscler Thromb Vasc Biol. 1997 ; 17: 156-163.
24. Pedreno J., Fernandez R. Proteolytic suspectibility of platelet low densitiy lipoprotein receptor. Lipids. 1995 ; 30: 927-933.
25. Endeman G., Stanton L., Madden K., Bryant K., While RT, Protter A. CD36 is a receptor for oxidized low density lipoproteins. J Biol Chem. 1993 ; 268: 1181-1186.
26. Hartwitch J., Dembinska-Kiec A., Gruca A., et al. Regulation of platelet adhesion by oxidized lipoproteins and oxidized phospholipids. Platelets. 2000 ; 13: 141-151.
27. Pedreno J., Hurt-Camejo E., Wiklund O., Masana L. CD36 is a specific receptor for native and modified low density lipoproteins. Atherosclerosis. 1997 ; 138-184.
28. Pytela R., Pierschbacher MD, Ginsberg MH, Plow EF, Rouslahti E. Membrane glycoprotein IIb/IIIa member of a family of Arg-Gly-Asp-specific adhesion receptors. Science. 1986 ; 231: 1559-1562.
29. Tetik S., Uras F., Yardimci KT Purification and characterization of human platelet fibrinogen receptor the GpIIb/IIIa complex. J Pharm Sci. 2005 ; 2: 155-162.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the folin phenol reagent J Biol Chem. 1951 ; 193: 265-275.
31. Laemnli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 ; 227: 680-685.
32. Tetik S., Yardimci KT, Eksioglu-Demiralp E. A flow cytometric method of ligand binding to isolated receptors using microbeads. In: Linkesch W, ed. Proceedings of the XVIIth Meeting of the International Society of Haemotology. 2003 ;210-213 (ISBN 88-323-3148-9).
33. Xia Z., Wong T., Liu Q., Kasirer-Freide A., Brown E., Frojmovic MM Optimally functional fluorescein isothiocyanate-labelled fibrinogen for quantative studies of binding to activated platelets and platelet aggregation. J Haematol. 1996 ; 93: 204-221.
34. Aviram M., Brook JG Platelet interaction with high and low density lipoproteins. Atherosclerosis. 1983 ; 46: 259-268.
35. Mazurov AV, Preobrazhensky SN, Leytin VL, Repin VS, Smirnov VN Study of low density lipoprotein interaction with platelets by flow cytofluorometry. FEBS Lett. 1982 ; 137: 319-322.
36. Koller E., Koller F., Binder BR Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane. J Biol Chem. 1989 ; 264: 12412-12418.
37. Lewing LLk, Kinoshita T., Nachman KL Isolation, purification and partial characterization of platelet membrane glycoproteins IIb and IIIa. J Biol Chem. 1980 ; 256: 1994-1997.
38. Jenning, LK Phillips DR Purification of glycoproteins IIb and IIIa from human plasma membranes and characterization of a calcium-dependent glycoprotein IIb/IIIa complex. J Biol Chem. 1982 ; 257: 10458-10466.
39. Phillip DR, Fitzgerald L., Paris L., Steiner B. Platelet receptors: assays and purification. Methods Enzymol. 1992 ; 215: 244-263.
40. Lefkovits J., Plow EF, Topol EJ Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995 ; 332: 1553-1559.
41. Koller E., Koller F., Doleschel W. Specific binding sites on human blood platelets for plasma lipoproteins. Hoppe-Seyler's Z Physiol Chem. 1982 ; 363: 395-405.
42. Curtiss LK, Plow EF Interaction of plasma lipoproteins with human platelets. Blood. 1984 ; 64: 365-374.
43. Ozsavci D., Yardimci T., Demirel GY, Uras F., Hekim N., Ulutin ON Apo A-I binding to platelets detected by flow cytometry. Thromb Res. 2001 ; 103: 117-122.
44. Ault K., Mitchell J. Analysis of platelets by flow cytometry. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Methods in Cell Biology: Flow Cytometry. San Diego, Calif: Academic Press Inc; 1994: 275-294.
45. Shattil SJ, Cunningham M., Hoxie JA Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987 ; 70: 307-315.
46. Ginsberg MH, Frelinger AL, Lam S., et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation specific monoclonal antibodies. Blood. 1990 ; 76: 2017-2023.
47. Sener A., Ozsavci D., Oba R., Yanikkaya-Demirel G., Uras F., Yardimci KT Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leucocyte aggregate formation occur simultaneously in hyperlipidemia ? Clin Biochem. 2005 ; 38: 1081-1087.
48. Tetik S., Yardimci KT, Ozsavci D., Uras F., Demiralp-Eksioglu E. HDL binding to human platelets and purified GpIIb/IIIa. In: Linkesch W, ed. Proceedings of the XVIIth Meeting of the International Society of Haemotology. 2003 ;205-209 (ISBN 88-323-3148-9).
49. Tetik S., Eksioglu-Demiralp E., Yardimci KT Effect of imatinib mesylate on platelet aggregation and fibrinogen binding to isolated platelets. Adv Mol Med. 2005 ; 1: 165-170.
50. Van Willigen G., Gorter G., Akkerman JW LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. J Arterioscler Thromb. 1994 ; 14: 41-46.
51. Sachais BS, Kuo A., Nassar T., et al. Platelet factor 4 binds to low-density lipoprotein rec eptors and disturbs the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. Blood. 2002 ; 15: 3613-3622.
52. Bochkov VN, Matchin YG, Fuk IV, Lyahishev AA, Tkachuk VA Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca (2+)-mobilizing activity of low-density lipoproteins. Atherosclerosis. 1992 ; 96: 119-124.
53. Tetik S. Evaluation of Relationship Between Platelet Fibrinogen Receptor GpIIb/IIIa (α iib/β iii) and Platelet LDL Receptor [PhD thesis]. Istanbul, Turkey: Institution of Health Scientific ; 2003.